Covidien Plans April U.S. Launch Of Solitaire For Ischemic Strokes
This article was originally published in The Pink Sheet Daily
Clot removal device gains 510(k) clearance earlier than expected, will compete with Stryker’s Merci clot retrieval system.
You may also be interested in...
New findings on deep brain stimulation, ischemic stroke devices, orthopedics and more.
Deal worth $325 million bolsters Covidien’s energy-based product offerings with Barrx Medical’s radiofrequency energy-based HaloFlex system for preventing esophageal cancer.
Covidien plans to double its sales in emerging markets, primarily China and India, to $2 billion over the next five to six years, CEO Jose E. Almeida said during the firm’s Sept. 8 investor meeting in New York.